Navigation Links
Surveyed Experts Indicate That Xarelto Has Advantages Over Lovenox in the Treatment of Venous Thromboembolism in Medically Ill Patients
Date:3/23/2009

Xarelto Will Earn Decision Resources' Clinical Gold Standard Status for VTE Prophylaxis in 2012, According to a New Report from Decision Resources

WALTHAM, Mass., March 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed cardiologists indicate that a therapy's effect on the prevention of venous thromboembolism (VTE) is the attribute that most influences their prescribing decisions for VTE prophylaxis in medically ill patients. Clinical data and the opinions of interviewed thought leaders indicate that Bayer/Johnson & Johnson's Xarelto has advantages in this attribute over Sanofi-Aventis's Lovenox, the sales-leading agent in the market.

The new report entitled Venous Thromboembolism Prophylaxis in Medically Ill Patients: Significant Opportunity Awaits Therapies Offering Improved Efficacy finds that an orally available therapy for VTE prophylaxis in medically ill patients would earn a 65 percent patient share in the United States and an 80 percent patient share in Europe, according to surveyed U.S. and European cardiologists.

In 2008, Decision Resources' proprietary clinical gold standard for VTE prophylaxis in medically ill patients was GlaxoSmithKline's Arixtra, owing largely to its efficacy. Based on available data and expert opinion, Xarelto will earn gold standard status for VTE prophylaxis in medically ill patients in 2012, following its approval for the indication in 2011.

"Xarelto has competitive advantages over Arixtra in terms of delivery and safety," said Decision Resources Analyst Christine Helliwell, Ph.D. "Xarelto's main advantage is that it causes a level of bleeding similar to that of Lovenox, whereas Arixtra suffers from a perception that it causes increased rates of bleeding over Lovenox."

About the Report

Venous Thromboembolis
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Grade Glioma
2. As a Result of the Jupiter Trial, 65 Percent of Surveyed MCO Pharmacy Directors Will Reimburse Crestor for Patients with Elevated hsCRP
3. Less Than Two-Thirds of Surveyed Pharmacy Directors Expect to Reimburse Both Onglyza and Alogliptin Once They are Available for the Treatment of Type 2 Diabetes
4. Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohns Disease
5. Half of Full-Time Employees Surveyed Dont Understand Health Insurance Coverage for Cancer-Related Medical Expenses
6. Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily
7. Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugais Actemra for Rheumatoid Arthritis
8. World Vision Index of Concern: Half of Americans Surveyed Said They Would Be Willing to Pay More Taxes to Combat AIDS
9. Experts from Africa and Asia to Discuss Maternal Health in Live Online Chat
10. FDA Experts to Speak at RAPS Horizons Conference
11. In Hepatitis C Virus Treatment, Interviewed Experts Indicate That Telaprevir- and Boceprevir-Based Regimens Have Advantages Over Pegasys/Ribavirin in Sustained Virologic Response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... Today the members of the new ... National Alliance-National Ovarian Cancer Coalition Translational Research Dream ... on “DNA Repair Therapies for Ovarian Cancer,” building ... as a common weakness in ovarian cancer. Researchers ... of ovarian cancer by developing a web-based approach ...
(Date:4/20/2015)... 2015 Alcohol-related incidents have been recognized ... States for decades. These result in billions of ... property damage each year, while inflicting an enormous emotional ... their families and loved ones. Throughout the year and ... dedicated to raising awareness of alcohol addiction—its societal impact ...
(Date:4/20/2015)... Insuranceautoquote.info has released a new blog post ... online . , Affordable auto insurance quotes can ... should always compare online car insurance rates in their ... website: . http://insuranceautoquote.info , The process is ... in a few minutes and the search engine offers ...
(Date:4/20/2015)... 20, 2015 The 2015 Market ... is a professional and in-depth study on the ... Market with a focus on the Chinese ... amlodipine besylate market research are Pfizer, Novartis, Daiichi ... Lab., Par Pharma, Cadila Pharmaceuticals, Kangya Pharmaceuticals, Rui ...
(Date:4/20/2015)... Vancouver, British Columbia (PRWEB) April 20, 2015 ... developer of a hand-held Cannabix Marijuana Breathalyzer for law ... release of the first publicly available images of its ... of its Cannabix Marijuana Breathalyzer. Media files and video ... are available for online viewing at cannabixtechnologies.com . ...
Breaking Medicine News(10 mins):Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 2Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 4Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 2Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 3Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 4Health News:Affordable Auto Insurance Quotes Can Be Found Online, Fast and Easy 2Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 2Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 3Health News:Cannabix Technologies Inc. Releases New Images of Marijuana Breathalyzer Prototype 2Health News:Cannabix Technologies Inc. Releases New Images of Marijuana Breathalyzer Prototype 3Health News:Cannabix Technologies Inc. Releases New Images of Marijuana Breathalyzer Prototype 4
... , , ATLANTA, ... announced today the opening of its first Asia office in ... in the United States and abroad. The new office will support the current ... including some of the world,s largest organizations. , , ...
... 28 Cambrex Corporation (NYSE: CBM ) announced that second quarter 2009 financial results will ... The Company will host a conference call to discuss the second quarter 2009 financial results. , ... Second Quarter 2009 Earnings Conference Call, When: ... Dial-in: 1-888-634-4003 for U.S., ...
... hope vaccine will be available by fall or early winter ... trials of a vaccine against the new H1N1 swine flu ... and Prevention will convene a panel of experts Wednesday to ... Those recommendations will assume that a safe and effective vaccine ...
... , , ... CVS ) announced today that it has named Andrew J. Sussman, ... retail-based health clinic subsidiary, and as Senior Vice President/Associate Chief Medical ... will be responsible for all clinical services and daily operations for ...
... ... ... dollars on new digital hearing aids need look no further. AidRight Hearing ... nationwide network of more than 1,200 professionals and offers discounts on a wide variety of ...
... MAITLAND, Fla. , July 28 The STAR ... with plagiocephaly and other head shape abnormalities, opened a third location ... also has offices in the Baltimore and Dallas areas, and has ... referred to as a cranial helmets or headbands. , , ...
Cached Medicine News:Health News:North Highland Opens First Asia Office in Shanghai 2Health News:CDC Panel to Recommend Who Should Get Swine Flu Shot 2Health News:CDC Panel to Recommend Who Should Get Swine Flu Shot 3Health News:CVS Caremark Names Andrew J. Sussman, M.D., as President/Chief Operating Officer of MinuteClinic 2Health News:CVS Caremark Names Andrew J. Sussman, M.D., as President/Chief Operating Officer of MinuteClinic 3Health News:Hearing Aid Savings Galore 2Health News:New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants 2Health News:New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants 3Health News:New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants 4Health News:New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants 5
(Date:4/20/2015)... April 20, 2015 The global ... segments the concerned global with analysis and forecast of ... and is estimated to reach $4,918.7 million by 2019, ... Browse through the TOC of global orthopedic ... of the industry trends and segments, with help of ...
(Date:4/20/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/7t5xlp/us_proton_therapy ... Proton Therapy Outlook - Market Opportunities" report to ... Therapy Outlook: Market Opportunities by the author, ... almost 29 such centers by 2018, a number which ... will breach the Billion dollar mark to attain revenue ...
(Date:4/20/2015)... , April 20, 2015  In its ... healthcare markets, the FTC announced that Cardinal Health, ... illegally monopolized 25 local markets for the sale ... and clinics to pay inflated prices for these ... pay $26.8 million of ill-gotten gains and represents ...
Breaking Medicine Technology:Global Orthopedic Braces & Support System Market is Expected to Reach $4,918.7 Million by 2019, at a CAGR of 4.4% from 2014 to 2019 2Global Orthopedic Braces & Support System Market is Expected to Reach $4,918.7 Million by 2019, at a CAGR of 4.4% from 2014 to 2019 3United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 2United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 3Cardinal Health Agrees to Pay $26.8 Million to Settle Charges It Monopolized 25 Markets for the Sale of Radiopharmaceuticals to Hospitals and Clinics, says FTC 2Cardinal Health Agrees to Pay $26.8 Million to Settle Charges It Monopolized 25 Markets for the Sale of Radiopharmaceuticals to Hospitals and Clinics, says FTC 3Cardinal Health Agrees to Pay $26.8 Million to Settle Charges It Monopolized 25 Markets for the Sale of Radiopharmaceuticals to Hospitals and Clinics, says FTC 4Cardinal Health Agrees to Pay $26.8 Million to Settle Charges It Monopolized 25 Markets for the Sale of Radiopharmaceuticals to Hospitals and Clinics, says FTC 5
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Data Show Valortim(R) Anthrax Anti-Toxin May Augment Immune System's Ability to Destroy Anthrax Bacteria 2Data Show Valortim(R) Anthrax Anti-Toxin May Augment Immune System's Ability to Destroy Anthrax Bacteria 3Data Show Valortim(R) Anthrax Anti-Toxin May Augment Immune System's Ability to Destroy Anthrax Bacteria 4Data Show Valortim(R) Anthrax Anti-Toxin May Augment Immune System's Ability to Destroy Anthrax Bacteria 5Data Show Valortim(R) Anthrax Anti-Toxin May Augment Immune System's Ability to Destroy Anthrax Bacteria 6Data Show Valortim(R) Anthrax Anti-Toxin May Augment Immune System's Ability to Destroy Anthrax Bacteria 7Data Show Valortim(R) Anthrax Anti-Toxin May Augment Immune System's Ability to Destroy Anthrax Bacteria 8WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai 2WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai 3WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai 4WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai 5WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai 6
The XK-95 High Speed Drill System sets new technological and performance standards for surgical drill systems....
Circular Spine Retractor System for microsurgical interventions in the lumbar and cervical spine region. The system has been approved in over 120 cases....
... The Ruggles Retractor System, a ... and the versatility of two systems ... hands from the surgical site during ... accurate retractor insertion. The retractor body ...
Fortitude as a unique complement to the spinal concepts family of products....
Medicine Products: